These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 11774474

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impaired entry of soluble receptor-resistant mutants of mouse hepatitis virus into cells expressing MHVR2 receptor.
    Matsuyama S, Taguchi F.
    Virology; 2000 Jul 20; 273(1):80-9. PubMed ID: 10891410
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Neurovirulence for mice of soluble receptor-resistant mutants of murine coronavirus JHMV.
    Matsuyama S, Watanabe R, Taguchi F.
    Adv Exp Med Biol; 2001 Jul 20; 494():145-8. PubMed ID: 11774459
    [No Abstract] [Full Text] [Related]

  • 5. Isolation and characterization of murine coronavirus mutants resistant to neutralization by soluble receptors.
    Saeki K, Ohtsuka N, Taguchi F.
    Adv Exp Med Biol; 1998 Jul 20; 440():11-6. PubMed ID: 9782259
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MHV neuropathogenesis: the study of chimeric S genes and mutations in the hypervariable region.
    Phillips JJ, Weiss SR.
    Adv Exp Med Biol; 2001 Jul 20; 494():115-9. PubMed ID: 11774454
    [No Abstract] [Full Text] [Related]

  • 9. Communication between S1N330 and a region in S2 of murine coronavirus spike protein is important for virus entry into cells expressing CEACAM1b receptor.
    Matsuyama S, Taguchi F.
    Virology; 2002 Mar 30; 295(1):160-71. PubMed ID: 12033774
    [Abstract] [Full Text] [Related]

  • 10. Role of the spike protein in murine coronavirus induced hepatitis: an in vivo study using targeted RNA recombination.
    Navas S, Seo SH, Chua MM, Das Sarma J, Hingley ST, Lavi E, Weiss SR.
    Adv Exp Med Biol; 2001 Mar 30; 494():139-44. PubMed ID: 11774458
    [No Abstract] [Full Text] [Related]

  • 11. Murine coronavirus-induced hepatitis: JHM genetic background eliminates A59 spike-determined hepatotropism.
    Navas S, Weiss SR.
    J Virol; 2003 Apr 30; 77(8):4972-8. PubMed ID: 12663803
    [Abstract] [Full Text] [Related]

  • 12. Involvement in fusion activity of an epitope in the S2 subunit of murine coronavirus spike protein.
    Taguchi F, Shimazaki YK.
    Adv Exp Med Biol; 2001 Apr 30; 494():213-8. PubMed ID: 11774471
    [No Abstract] [Full Text] [Related]

  • 13. Identification of spike protein residues of murine coronavirus responsible for receptor-binding activity by use of soluble receptor-resistant mutants.
    Saeki K, Ohtsuka N, Taguchi F.
    J Virol; 1997 Dec 30; 71(12):9024-31. PubMed ID: 9371559
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of amino acid insertions in the cysteine-rich domain of the MHV-A59 spike protein on cell fusion.
    Chang KW, Gombold JL.
    Adv Exp Med Biol; 2001 Dec 30; 494():205-11. PubMed ID: 11774470
    [No Abstract] [Full Text] [Related]

  • 18. Analysis of the receptor-binding site of murine coronavirus spike protein.
    Suzuki H, Taguchi F.
    J Virol; 1996 Apr 30; 70(4):2632-6. PubMed ID: 8642698
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.